Carboplatin and paclitaxel in advanced or metastatic endometrial cancer
- 1 May 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 109 (2), 250-254
- https://doi.org/10.1016/j.ygyno.2008.01.028
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupAnnals of Oncology, 2003
- Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group studyGynecologic Oncology, 2003
- Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer GroupEuropean Journal Of Cancer, 2003
- A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Treatment of Advanced or Recurrent Endometrial Carcinoma with Single-Agent CarboplatinGynecologic Oncology, 1993
- Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group studyGynecologic Oncology, 1989
- Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma A Gynecologic Oncology Group studyAmerican Journal of Clinical Oncology, 1984